News

The topic for the Grand Challenge Grant is low cost diagnostics for global priory health conditions, which includes both malaria and tuberculosis. Clayton Hardman, CEO of Biomagnetics Diagnostics,

The randomised phase II trial treats patients with unresectable or metastatic soft tissue sarcoma in the front- and second-line setting. Patients are randomised either to doxorubicin (the only

Arkema has presented to its Balan facility’s trade union representatives a plan to shut-down a 30,000 ton PVC production unit on the site in order to strengthen the

PPD has completed its acquisition of Excel, a contract research organisation in China. The acquisition strengthens PPD’s full range of drug development services in the country and positions

Aurobindo Pharma (Aurobindo) has received the final approval for Lamotrigine tablets (chewable, dispersible) 5mg and 25mg from the FDA. Lamotrigine tablets 5mg and 25mg is generic equivalent to

Novexel has initiated Phase II clinical trial for advanced oral antibacterial NXL103 (flopristin/linopristin) in adults with acute bacterial skin and skin structure infections (ABSSSI). The trial is designed

The House of Representatives has approved new and stringent standards for chemical site security, pushing forth with efforts to mandate product substitution in a misguided attempt to safeguard

Boston Scientific has reached an agreement, in principle, with the US Department of Justice (DOJ) related to product advisories issued by its Guidant subsidiary in 2005. The alleged

Xoma has expanded its development strategy for its XOMA 052 antibody to interleukin-1 beta (IL-1 beta) to include effects on cholesterol lowering, reducing plaque deposits and damage to